Clostridium diffi cile infection (CDI) is a common hospital-acquired infection with increasing incidence, severity, recurrence, and associated morbidity and mortality. There are emerging data on the occurrence of CDI in nonhospitalized patients. However, there is a relative lack of community-based CDI studies, as most of the existing studies are hospital based, potentially infl uencing the results by referral or hospitalization bias by missing cases of community-acquired CDI.
INTRODUCTION
Clostridium diffi cile is recognized as the primary infectious cause of pseudomembranous colitis ( 1 ) and the principal cause of infectious diarrhea in hospitalized patients ( 2 ) . Recent studies have shown increasing incidence, severity, and recurrence rates of C. diffi cile infection (CDI) ( 3 -9 ) . For example, the incidence of health-care-acquired CDI increased 2 -2.5-fold from the late 1990s to the early 2000s, and even more in the elderly ( 7, 10 ) . Th ere has also been a signifi cant increase in severe cases, colectomies, and death related to CDI ( 7, 11, 12 ) . However, most of the recent literature assessing these trends in CDI is based on hospitalized patients, and hence is potentially infl uenced by hospitalization or referral biases. A few studies have described the emergence of community-acquired CDI ( 13 -15 ) , but there is a lack of population-based studies describing CDI. We assessed CDI incidence, risk factors, and outcomes in a population-based cohort, including community-acquired infections in outpatients as well as hospitalized inpatients.
METHODS

Study population
All potential cases of CDI occurring in residents of Olmsted County, Minnesota, between 1991 and 2005 were identifi ed
The Epidemiology of Community-Acquired Clostridium diffi cile Infection: A Population-Based Study using the resources of the Rochester Epidemiology Project (REP) ( 16, 17 ) . Th e REP diagnostic index was searched for the ICD-9 (International Classifi cation of Diseases, 9th Edition) code for CDI (008.45), along with CDI as microbiological or clinical diagnoses (for both inpatients and outpatients). All medical records, from all sources of care available to Olmsted County residents, are linked and accessible through the REP. Th ese medical records contain all information regarding diagnoses, hospital admissions, surgical procedures, results of hematological and laboratory tests, imaging, vaccinations, and drug prescriptions for all county residents. Th e REP therefore allows investigators to follow subjects through their outpatient and hospitalization contacts across all local medical facilities, regardless of where the care was delivered and of insurance status. A central diagnostic index maintains records from all outpatient visits, emergency room visits, hospitalizations, nursing home visits, surgical procedures, autopsy examinations, and death certifi cates for all residents since 1908.
Aft er identifi cation of possible cases of CDI, records of patients who had provided permission (according to Minnesota state law) for their medical records to be used in research were reviewed. Clinical notes, laboratory results, and endoscopy and histo pathology reports were reviewed to confi rm diagnoses. Records were reviewed to identify separate cases for individual patients and determine acquisition modality (community vs. hospital). Comorbidities for all patients were assessed by calculating the crude Charlson comorbidity index ( 18 ) . Th e Charlson comorbidity index comprises 19 comorbid conditions in 4 categories, and each category has a weighted score based on the adjusted risk of 1-and 10-year mortality ( 18 ) . A higher Charlson score refl ects a more severe comorbidity burden and an increased likelihood of 1-and 10-year mortality. Acidsuppressing medication use was defi ned as the use of either a proton-pump inhibitor or a histamine-2 receptor blocker at the time of CDI diagnosis. Antibiotic exposure was defi ned as the use of oral or parenteral antibiotics in the 90 days preceding CDI diagnosis. Infl ammatory bowel disease was defi ned as the presence of diagnosed ulcerative colitis, Crohn ' s disease, or indeterminate colitis. Th e presence of a malignancy was defi ned as a current or previous diagnosis of a localized or metastasized solid tumor, lymphoma, or leukemia. Th e Mayo Clinic and Olmsted Medical Center Institutional Review Boards approved the study.
Case defi nitions
Based on practice recommendations ( 19, 20 ) , " defi nite " CDI was defi ned as ≥ 3 loose stools in 24 h with a positive C. diffi cile stool toxin assay or the presence of pseudomembranous colitis on endoscopy or histology. Recurrent CDI was defi ned if these diagnostic criteria were met within 8 weeks of initial diagnosis aft er documented symptom resolution ( 5, 8, 19 ) . Severe disease was defi ned by a white blood cell count of ≥ 15,000 / mm 3 or a serum creatinine rise of > 50 % from baseline ( 20 ) . CDI was classifi ed as " severe complicated " if the infection was associated with hypotension, sepsis, ileus, toxic megacolon, perforation, need for intensive care unit admission, surgery for a CDI-related complication, or death ( 20 ) .
Infection was defi ned as hospital-acquired if onset of symptoms occurred > 48 h aft er admission to, or less than 4 weeks aft er discharge from, a health-care facility ( 20 ) . Infection was defi ned as community-acquired if onset of symptoms occurred in the community or within 48 h of admission to a hospital, provided symptom onset was > 12 weeks aft er the last discharge from a hospital. Infection was defi ned as indeterminate if symptom onset occurred between 4 and 12 weeks from a hospital dismissal ( 20 ) . Indeterminate cases ( n = 20) were included as community-acquired for the purposes of this study. Secular trends were analyzed to assess for changes in severity (based on change in complication rates), initial treatment and response, and likelihood to relapse over time.
Statistical analysis
Th e incidence of confi rmed cases of CDI in Olmsted County residents at the time of their diagnosis was calculated per 100,000 person-years. Th e 2000 US census data were used to calculate age-and sex-adjusted rates (direct adjustment to the age and gender distribution of US whites, 2000). Poisson regression models were used to evaluate the association of age, sex, and calendar period with crude incidence rates and mode of infection acquisition (community-acquired vs. hospital-acquired infection). Th e univariate associations of demographic and clinical characteristics with mode of acquisition were assessed via contingency tables analyses ( χ 2 test). As the REP captures data on both inpatients and outpatients, and data on annual hospital days for county residents is available, the incidence rates for both community-acquired CDI (per 100,000 person-years) and, separately, hospital-acquired CDI (per 100,000 bed-days) were calculated. When calculated separately, hospital-acquired rates were not adjusted to US census data as described above, but hospital-acquired cases were included in the overall incidence calculations and were adjusted appropriately.
In Olmsted County, certain nursing homes are coupled with assisted living facilities. Th us, some residents of these facilities are similar to hospitalized patients, whereas others are closer to community dwellers. Th erefore, for the purposes of this study, patients residing in long-term care facilities were included in the overall results, but not in subanalyses of community-vs. hospital-acquired infection.
RESULTS
Incidence of community-acquired CDI
A total of 416 possible cases of CDI were identifi ed; 31 (7.5 % ) cases were excluded, 30 because of lacked of a confi rmatory stool assay and 1 because of lack of authorization to access records for research. Th us, 385 (92.5 % ) cases met criteria for " defi nite " CDI and were included in this study. Patient classifi cation into community-and hospital-acquired CDI is shown in Figure 1 . Th e median age was 67.6 years (range 1 month to 102 years), and 65.7 % patients were female. Th e majority (53 % )
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Community-Acquired C. difficile Epidemiology of cases occurred in elderly patients ( ≥ 65 years of age); 50 % were hospital-acquired, 9 % were nursing home acquired, and a substantial proportion (41 % ) of cases were communityacquired. Of all CDI patients, 87 % had documented antibiotic exposure in the preceding 90 days. Other patient characteristics are shown in Table 1 .
Th e overall age-and sex-adjusted incidence of CDI was 25.2 / 100,000 person-years. A signifi cant increase in incidence rates by age ( P < 0.001) and calendar period ( P < 0.001) was observed ( Figure 2a,b ) . Th e increase in incidence was most striking in the elderly ( Figure 3 ) . Th e eff ect of age on incidence rates did not change over the diff erent calendar periods.
Th e age-and sex-adjusted incidence for community-acquired CDI was 9.6 per 100,000 person-years. Th e incidence of communityacquired CDI increased with age ( Figure 2c , P < 0.001) and calendar period, with a 5.3-fold increase over the study period (from 2.8 per 100,000 person-years in 1991 -1993 to 14.9 per 100,000 person-years in 2003 -2005; Figure 2d , P < 0.001). Th e crude incidence for hospital-acquired CDI was 16.6 per 100,000 beddays. Th e incidence of hospital-acquired CDI also increased with age ( Among cases of CDI in the elderly, 24 % were communityacquired, 60 % were hospital-acquired, and 16 % were nursing home acquired. Also, the overall incidence of CDI in the elderly was higher than in younger patients in all time intervals, and the incidence in elderly subjects increased signifi cantly over the study period ( P < 0.01; Figure 3 ).
Community-acquired CDI: clinical features
Characteristics of the community-acquired and hospital-acquired cohorts are shown in Table 1 . Older age was associated with mode of acquisition (60 % of elderly cases were hospital-acquired compared with 39 % of younger cases, P < 0.001). Community-acquired patients were younger and more likely to be female than hospitalacquired patients. Antibiotic use was also associated with mode of acquisition, with community-acquired CDI patients being less likely to have used antibiotics in the 90-day period before diagnosis. Community-acquired CDI patients were less likely to have comorbidities (as demonstrated by a signifi cantly lower mean Charlson index scores) and were less likely to be on an acidsuppressing medication ( Table 1 ) .
Outcomes of community-acquired CDI
Laboratory markers of severity were not available in 91 CDI cases (24 % ). In the patients who had these markers assessed, 106 (36 % ) had severe infection. Complications from CDI occurred in 27 cases (7 % ). Th e proportion of severe ( P = 0.30) and complicated cases ( P = 0.94) did not change signifi cantly over the study period.
Upon initial analysis, the proportion of patients with severe infection was not associated with mode of acquisition ( Table 1 ) . However, 32 % of patients with community-acquired CDI and 16 % with hospital-acquired CDI did not have the markers of * These were included as community-acquired for analysis for this study severity (serum creatinine and white blood cell count) measured. Repeating data analysis considering all the patients for whom the markers of severity were not available as not having severe infection indicated that community-acquired infection was signifi cantly less likely to be severe than hospital-acquired infection (20 % vs. 31 % , P < 0.01). Excluding the patients who acquired CDI while in a nursing home, mode of acquisition was not signifi cantly associated with severe-complicated CDI ( Table 1 ) . Elderly patients were more likely than younger patients to have severe infection (43 % vs. 28 % , P = 0.008), and severe complicated infection (11 % vs. 3 % ; P = 0.002). Colectomy was required in two patients secondary to CDI. Th ere were 16 deaths (4.2 % ) attributed to CDI in our cohort, with 9 deaths in hospital-acquired CDI, 4 in community-acquired CDI, and 3 in nursing home -acquired CDI.
Th e risk of recurrent CDI in patients with community-acquired infection was 28 % , which was not signifi cantly diff erent than in patients with hospital-acquired infection ( P = 0.66), and did not vary signifi cantly over the study period.
Hospitalization was required in 63 cases (40 % ) with community-acquired infection. Th is proportion did not change significantly over the study period. Th e need for hospitalization was associated with age; among the elderly community-acquired cases, 61 % required hospitalization, compared with 31 % in younger patients ( P < 0.001). Elderly patients with community-acquired infection were twice as likely to need hospitalization as younger patients.
DISCUSSION
CDI has been traditionally thought of as a hospital-acquired or health-care-associated infection. However, data from this population-based cohort suggest that a substantial fraction of CDI cases were acquired in the community. We also found a signifi cant increase in the incidence of CDI in both inpatients and out patients over the study period and, as seen previously, this increase in CDI incidence was most striking in the elderly. Most importantly, our results demonstrate that CDI aff ects populations previously thought to be at low risk, including young adults and children, and those who lack the traditional risk factors of hospitalization or antibiotic exposure. In this cohort, community-acquired CDI was common in younger patients (61 % of younger patients acquired infection in the community), the majority of patients were females, and many of them (22 % ) were not exposed to antibiotics in the 90-day period before acquiring CDI. A recent epidemiological study showed a similar gender distribution and 98.3 % of community-acquired CDI cases occurred in patients < 65 years of age ( 15 ) . In a case -control study of community-acquired CDI, antibiotic exposure was not present in 52 % of CDI patients in the 4-week time period before onset ( 13 ) . In our study, there were no diff erences in acidsuppression medication use in the community-and hospitalacquired CDI patients. Other studies of community-acquired CDI have reported a similar lack of antibiotic and proton-pump inhibitor exposure ( 14, 15 ) . Th ese observations suggest that there may be additional or diff erent risk factors for communityacquired CDI.
Th e diff erence in age based on mode of acquisition was expected ( 4, 21 ) , as hospitalized patients tend to be older than community dwellers in general. However, the communityacquired CDI cohort also was more likely to be female than the hospital-acquired cohort. Th e reason for the diff erence in gender is not clear. We considered that it might be related to diff erential exposure to antibiotics, with females being more likely to seek medical attention (and therefore be exposed to antibiotics) in the outpatient setting than males, whereas in hospitalized patients, exposure to antibiotics is less likely to be related to gender. However, we found no signifi cant association between gender and antibiotic use, and the eff ect of gender on acquisition mode was not modifi ed by antibiotic use.
In our cohort, there were no diff erences in severity or recurrence rates between community-acquired and hospital-acquired CDI on initial analysis. However, the lack of diff erence in severity should be interpreted with caution. A signifi cant proportion of patients did not have the markers of severity (serum creatinine and white blood cell count) measured. Assuming that these Severe complicated CDI, n ( % )
7 (5) 14 (7) 0.27
Recurrent CDI, n ( % ) 44 (28) 58 (30) 0.66 CDI, Clostridium diffi cile infection. Nursing home patients were not included in the comparison of community-and hospital-acquired CDI. a Defi ned as white blood cell count ≥ 15,000 / mm 3 or ≥ 50 % rise in serum creatinine. Denominators indicate the number of subjects who had at least one of the severity markers assessed. b Secondary data analysis assuming that patients for whom the markers of severity were not available were not having severe CDI.
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Th ere has been a signifi cant increase in severe cases, colectomies, and death related to CDI in recent reports ( 7, 12 ) . In one of these studies, severe disease was present in 12 % of patients, but was 2.7-fold higher in the elderly ( 22 ) . Th e rates for colectomy and mortality secondary to CDI has increased from 2.5-fold to 5-fold in diff erent studies from 1993 to 2004 ( 23 -25 ) . Using the recent consensus defi nitions ( 20 ) , severe disease occurred in 36 % of our cohort and severe complicated occurred in 7 % , with no signifi cant change over the study period. As reported previously, patients were not so severely ill as to warrant a clinician to order these tests, we reanalyzed the data considering patients in whom these markers were not available as having mild -moderate infection. Th is secondary analysis suggested that communityacquired infection was signi fi cantly less likely to be severe than hospital-acquired infection.
As reported previously, we also found that CDI was more common and more severe in the elderly and that the increase in incidence over the study period was most striking in the oldest subset of our cohort. A majority of the elderly cases were hospitalacquired, and were more likely to have severe or severe complicated 1 9 9 1 -1 9 9 3 1 9 9 4 -1 9 9 6 1 9 9 7 -1 9 9 9 2 0 0 0 -2 0 0 2 2 0 0 3 -2 0 0 5 2 0 -2 9 3 0 -3 9 4 0 -4 9 5 0 -5 9 6 0 -6 9 7 0 -7 9 8 0 + 0 -1 9 1 9 9 1 -1 9 9 3 1 9 9 4 -1 9 9 6 1 9 9 7 -1 9 9 9 2 0 0 0 -2 0 0 2 2 0 0 3 -2 0 0 5 2 0 -2 9 3 0 -3 9 4 0 -4 9 5 0 -5 9 6 0 -6 9 7 0 -7 9 8 0 + 0 -1 9 1 9 9 1 -1 9 9 3 1 9 9 4 -1 9 9 6 1 9 9 7 -1 9 9 9 2 0 0 0 -2 0 0 2 2 0 0 3 -2 0 0 5 2 0 -2 9 3 0 -3 9 4 0 -4 9 5 0 -5 9 6 0 -6 9 7 0 -7 9 8 0 + Figure 2 . Incidence rates of Clostridium diffi cile infection in Olmsted County, Minnesota. The top two panels show the incidence data for the overall study population, both ( a ) age-specifi c and ( b ) age-and gender-adjusted rates over time. The middle two panels show the incidence of community-acquired infection, both ( c ) age-specifi c and ( d ) age-and gender-adjusted rates over time. The lower two panels show the incidence of hospital-acquired infection, both ( e ) age-specifi c and by ( f ) calendar period.
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both occurred in a signifi cantly higher proportion of the elderly in our study. Our fi ndings are consistent with several other reports that show an increase in the incidence and severity of CDI worldwide since the mid to late 1990s ( 3,5,7,10,12,15,26 -29 ) . For example, there was a large outbreak in Quebec, with a fourfold increase in CDI, increasing severity and, unlike in our study, a 2.3-fold increased risk of recurrence (47 % compared with 21 % ) over a 13-year period, with a mortality of 6.9 % ( 5, 8, 27, 30 ) . Th e Canadian Nosocomial Infection Surveillance Program Study estimated the incidence rate for CDI in adult patients admitted to hospitals as 4.6 cases per 1,000 patient admissions and 65 per 100,000 patient-days ( 31 ), which was fourfold higher than the overall crude incidence rate observed in our cohort. However, these studies did not include community-dwelling subjects with CDI, which would lead to an overestimate of overall incidence as the incidence in community dwellers is lower than in hospitalized subjects. In addition, we chose to exclude 30 patients with probable CDI because of lack of a confi rmatory stool assay.
In large retrospective studies in the United States, the incidence of hospital-acquired CDI increased by 2 -2.5-fold from the late 1990s to the early 2000s, especially in the elderly ( 7, 10 ) . Th e rate of hospitalization due to CDI increased by ~ 23 % per year from 2000 to 2005 ( 25 ) , but from 2005 through 2006, the rate increased by only 6.7 % ( 28 ). In contrast, in our cohort, the rate of hospitalization for community-acquired CDI did not vary signifi cantly over the study period.
Th e majority of CDI epidemiological data are derived from hospital-based reports and administrative databases, such as the US National inpatient sample data and the national mortality data for CDI surveillance ( 24, 25, 29 ) . Th ere have been relatively few studies describing the epidemiology and characteristics of community-acquired CDI ( 4, 13, 15, 21, 32, 33 ) . Most of the CDI studies use hospital discharge data and laboratory data as the primary source of case identifi cation. Th e use of hospital discharge data has the potential to miss community-acquired cases, and laboratory databases have the potential to include false positive CDI as these patients might be colonized with C. diffi cile but not have symptomatic infection.
Th e major strength of our study is that data have been collected over a period of 15 years from a stable population. Collecting data from a population-based cohort allowed us to study and compare the epidemiology of CDI in both hospitaland community-acquired cohorts. Th e resources of the REP allowed the identifi cation of all cases of CDI in county residents and access to all the medical record information for each case. However, we were unable to analyze of trends in the use of C. diffi cile stool testing in county residents over the study period because of unavailability of these data, thus limiting our ability to assess for diagnostic detection bias. Other limitations of this study include some missing data, such as laboratory tests used for defi ning severe CDI, and lack of information on C. diffi cile strain, which was not being collected in our laboratory during the time period of this study. Finally, during the course of this study, the diagnostic test for CDI transitioned from stool cytotoxicity assay to enzyme immunoassay. As enzyme immunoassay has a lower sensitivity than the cytotoxicity assay, it is likely that this change in diagnostic test underestimated the true increase in incidence that we saw over the study period.
In conclusion, the incidence of CDI increased signifi cantly over time in both community-dwelling and hospitalized Olmsted county residents. A signifi cant proportion of CDI occurred in community dwellers who were younger, less likely to have been exposed to antibiotics, and less likely to have severe infection than patients with hospital-acquired infection. A signifi cant proportion of CDI cases would be missed and demographic and severity data would be skewed if hospital data were used as the only source for CDI epidemiological studies. Given the signifi cant proportion of our cohort who had community-acquired infection, CDI should be considered in all outpatients with acute diarrhea.
